Practice Point® CME Podcasts: Expert Discussions in Rare Diseases™

Practice Point Communications

In these podcasts, we dive deep into the world of rare diseases, where every story is unique and every diagnosis a challenge. The episodes highlight the personal journeys of patients and medical professionals as they navigate the complexities of rare conditions. Each episode features expert insights on cutting-edge research, emerging treatments, and the social and emotional aspects of living with a rare disease. These podcasts are your guide to understanding and advocating for those affected by these often misunderstood conditions.

  1. Episode 26 - Patient-Focused Strategies to Effectively Diagnose, Treat, and Manage NF1-PN

    10/16/2025

    Episode 26 - Patient-Focused Strategies to Effectively Diagnose, Treat, and Manage NF1-PN

    This activity will provide a comprehensive overview of NF1-PN and will dive deeper into the nuances of treating and managing adult patients with inoperable symptomatic NF1-PN. Dr. Angela Hirbe will use clinical cases to illustrate best-practice approaches to optimally identify adult patients with NF1-PN that will benefit from approved MEK inhibitors and will detail how to choose between agents and address/prevent adverse effects. The work-up and monitoring recommendations will also be discussed and any insights for achieving improved outcomes among diverse patients will be detailed. This presentation will empower participants to make informed clinical decisions for different patients with distinct needs. Launch/Release Date: October 16, 2025 Activity Expiration Date: September 30, 2026 FACULTY Angela Hirbe, MD, PhD Associate Professor of Medicine and Pediatrics Director Adult Neurofibromatosis Clinical Program Division of Oncology Sarcoma Section Washington University School of Medicine St. Louis, Missouri This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    33 min
  2. Episode 25 - Recent Progress in NF1-PN: Pathophysiology, Role of MEK Inhibitors, Recognizing the NF1-PN Patient

    10/06/2025

    Episode 25 - Recent Progress in NF1-PN: Pathophysiology, Role of MEK Inhibitors, Recognizing the NF1-PN Patient

    This activity will inform participants about the complex pathophysiology of NF1-PN and how an understanding of molecular pathways has led to the development of MEK inhibitors. The key published and ongoing clinical evidence on the utility of approved and emerging therapies for NF1-PN will be detailed to provide a strong foundation for clinical decision-making. An in-depth guide to recognize and diagnose patients with NF1-PN will also be discussed in this module to facilitate an accurate and timely diagnosis. Overall, this presentation will ensure that participants appreciate the need to recognize and treat NF1-PN among pediatric patients. Launch Date/Release Date: October 6, 2025 Expiration Date: September 30, 2026 FACULTY Amy Armstrong, MD Assistant Professor of Pediatrics Division of Hematology/Oncology Neurofibromatosis (NF) Center Washington University School of Medicine St. Louis, Missouri This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    58 min
  3. Episode 24 - Precision in Practice: Elevating Care for Uncontrolled Gout

    09/23/2025

    Episode 24 - Precision in Practice: Elevating Care for Uncontrolled Gout

    Gout remains the most common form of inflammatory arthritis in adults, yet it continues to be one of the most misunderstood and mismanaged chronic diseases in clinical practice. Despite clear treatment guidelines and a growing array of therapeutic options, a substantial proportion of patients experience persistent flares, disease progression, and comorbid complications due to clinical inertia, fragmented care, and limited provider awareness of emerging innovations. This podcast, presented by Dr. Robert Terkeltaub, seeks to modernize clinical approaches to gout, accelerate the adoption of new evidence and therapies, and ultimately improve the quality and consistency of care for a patient population long underserved by existing education. Launch Date/Release Date: September 23, 2025 Expiration Date: August 31, 2026 FACULTY Robert Terkeltaub, MD Professor Emeritus of Medicine, University of California, San Diego This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    1h 4m
  4. Episode 23 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 7 - The Future of Stroke Prevention - What's Next?

    08/25/2025

    Episode 23 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 7 - The Future of Stroke Prevention - What's Next?

    Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk. Launch Date: August 25, 2025 Release Date: August 25, 2025 Expiration Date: July 31, 2026 FACULTY C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC Interventional Cardiologist Beth Israel Lahey CEO Baim Institute for Clinical Research Professor of Medicine Harvard Medical School Manesh Patel, MD Richard Sean Stack, M.D. Distinguished Professor Professor of Medicine Chief, Division of Cardiology Duke University Health System This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    13 min
  5. Episode 22 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 6 - Case Study Challenge - Applying Knowledge to Patient Care

    08/25/2025

    Episode 22 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 6 - Case Study Challenge - Applying Knowledge to Patient Care

    Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk. Launch Date: August 25, 2025 Release Date: August 25, 2025 Expiration Date: July 31, 2026 FACULTY C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC Interventional Cardiologist Beth Israel Lahey CEO Baim Institute for Clinical Research Professor of Medicine Harvard Medical School Manesh Patel, MD Richard Sean Stack, M.D. Distinguished Professor Professor of Medicine Chief, Division of Cardiology Duke University Health System This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    12 min
  6. Episode 21 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 5 - Practical Considerations - How Will FXIa Inhibitors Fit Into Stroke Prevention?

    08/25/2025

    Episode 21 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 5 - Practical Considerations - How Will FXIa Inhibitors Fit Into Stroke Prevention?

    Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk. Launch Date: August 25, 2025 Release Date: August 25, 2025 Expiration Date: July 31, 2026 FACULTY C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC Interventional Cardiologist Beth Israel Lahey CEO Baim Institute for Clinical Research Professor of Medicine Harvard Medical School Manesh Patel, MD Richard Sean Stack, M.D. Distinguished Professor Professor of Medicine Chief, Division of Cardiology Duke University Health System This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    17 min
  7. Episode 20 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 4 - Clinical Data Deep Dive - What Clinical Trials Tell Us

    08/25/2025

    Episode 20 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 4 - Clinical Data Deep Dive - What Clinical Trials Tell Us

    Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk. Launch Date: August 25, 2025 Release Date: August 25, 2025 Expiration Date: July 31, 2026 FACULTY C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC Interventional Cardiologist Beth Israel Lahey CEO Baim Institute for Clinical Research Professor of Medicine Harvard Medical School Manesh Patel, MD Richard Sean Stack, M.D. Distinguished Professor Professor of Medicine Chief, Division of Cardiology Duke University Health System This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    26 min
  8. Episode 19 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 3 - Understanding Residual Stroke Risk and the Consequences of Undertreatment

    08/25/2025

    Episode 19 - Rethinking Stroke Prevention: Addressing the Unmet Needs in Antithrombotic Therapy - Part 3 - Understanding Residual Stroke Risk and the Consequences of Undertreatment

    Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk. Launch Date: August 25, 2025 Release Date: August 25, 2025 Expiration Date: July 31, 2026 FACULTY C. Michael Gibson, MD, MS, MA, FRCP, FAHA, FSCAI, FACC Interventional Cardiologist Beth Israel Lahey CEO Baim Institute for Clinical Research Professor of Medicine Harvard Medical School Manesh Patel, MD Richard Sean Stack, M.D. Distinguished Professor Professor of Medicine Chief, Division of Cardiology Duke University Health System This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    22 min
See All (26)

About

In these podcasts, we dive deep into the world of rare diseases, where every story is unique and every diagnosis a challenge. The episodes highlight the personal journeys of patients and medical professionals as they navigate the complexities of rare conditions. Each episode features expert insights on cutting-edge research, emerging treatments, and the social and emotional aspects of living with a rare disease. These podcasts are your guide to understanding and advocating for those affected by these often misunderstood conditions.

Information